This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Aetiology

Authoring team

  • alcoholic liver disease
  • viral hepatitis - types B, C and delta
  • metabolic:
    • haemochromatosis - primary and secondary
    • Wilson's disease
    • alpha-1 anti-trypsin deficiency
    • type IV glycogenosis }
    • galactosaemia } very rare
    • congenital tyrosinosis }
  • primary biliary cirrhosis; secondary biliary cirrhosis
  • "lupoid" hepatitis / autoimmune chronic active hepatitis
  • hepatic venous outflow obstruction:
    • venoocclusive disease
    • Budd Chiari syndrome
    • "cardiac cirrhosis" from constrictive pericarditis
  • toxins/ drugs e.g. methrotrexate, amiodarone, bush tea
  • intestinal bypass
  • indian childhood cirrhosis - India, SE Asia, Middle East
  • cryptogenic - heterogenous group of unknown origin

Notes:

  • the most common causes are alcohol, 60-80%; viral hepatitis, 10-20%; biliary cirrhosis, 5-10%; haemochromatosis, 5%
  • the frequency of cryptogenic cirrhosis is variable - in the UK, it accounts for about 30% of cases but in other countries such as France and the urban parts of the USA, it is less prevalent and alcohol more so
  • in granulomatous lesions such as brucellosis, sarcoidosis and tuberculosis, fibrosis is not followed by nodular regrowth i.e. not cirrhosis
  • syphilis causes cirrhosis in neonates but not adults
  • schistosomiasis causes fibrosis but not cirrhosis

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.